Heart infection involving ICD associated with high rate of complications, risk of death

April 24, 2012

Patients with infective endocarditis involving implanted cardiac devices experience a high rate of complications such as valve infections, heart failure, and persistent bacteremia, and high in-hospital and 1-year mortality rates, particularly if there is valve involvement, according to a study in the April 25 issue of JAMA.

"Cardiac , including permanent pacemakers and implantable cardioverter-defibrillators (ICDs), are increasingly implanted worldwide, with estimates of more than 4.2 million with a permanent or ICD implanted in the United States between 1993 and 2008. Cardiac device infection is a serious, emerging disease with a 210 percent increase in incidence between 1993 and 2008. In-hospital charges for this complication are estimated to be at least U.S. $146,000 per case," according to background information in the study. "The management of cardiac device infective endocarditis (CDIE) is complex and usually requires prolonged , percutaneous or surgical removal of the device, and possible device reimplantation."

Eugene Athan, M.D., of Barwon Health, Geelong, Australia, and colleagues conducted a study to examine the characteristics and outcome of CDIE with attention to health care-associated infection and to determine associated with in-hospital and 1-year mortality and outcomes following device removal. The study, which used data from the on Endocarditis-Prospective Cohort Study (ICE-PCS), was conducted from June 2000 through August 2006 in 61 centers in 28 countries.

Cardiac device infective endocarditis was diagnosed in 177 (6.4 percent) of the total cohort of 2,760 patients with definite infective endocarditis, including 152 (85.9 percent) patients with a permanent pacemaker, 21 (11.9 percent) patients with an ICD, and 4 (2.3 percent) patients with device type not specified. Patients were predominantly men (74.0 percent), with a median (midpoint) age of 71 years. Blood cultures were positive in 149 patients (84.2 percent), and isolates were predominantly staphylococcal (Staphylococcus aureus, 35.0 percent; coagulase-negative staphylococci, 31.6 percent).

The researchers found that 26 of the patients with CDIE (14.7 percent) died during the index hospitalization, including 18 of 141(12.8 percent) who underwent device removal and 8 of 34 (23.5 percent) who did not. Between hospital discharge and 1-year follow-up, 15 patients died and 10 were lost to follow-up. Overall, of the 177 patients with CDIE enrolled, 126 (71.2 percent) were alive at 1 year and 41 (23.2 percent) had died.

Coexisting valve infection was found in 66 patients (37.3 percent); other complications included (15.3 percent) and persistent bacteremia (15.8 percent). "Several of these complications were found to be associated with in-hospital and 1-year mortality in patients with CDIE. The high rates of mortality emphasize the need for improved preventive measures, including optimal skin decontamination and appropriate antibiotic administration at the time of cardiac device insertion or manipulation, as well as careful attention to any invasive or intravascular procedures performed after device implantation," the authors write.

Health care-associated infection was identified in 81 (45.8 percent) patients with CDIE, including 61 (34.5 percent) with nosocomial (hospital-acquired) and 20 (11.3 percent) with nonnosocomial infections.

Additional analysis showed a survival benefit at 1 year for device removal during the initial hospitalization (28/141 patients [19.9 percent] who underwent device removal during the index hospitalization had died at 1 year, vs. 13/34 [38.2 percent] who did not undergo device removal).

"Given that numbers of cardiovascular implantable electronic devices placed are increasing rapidly, further studies on the prevention and treatment of this serious complication are needed," the authors conclude.

Explore further: Surgery improves endocarditis-induced heart failure survival rates

More information: JAMA. 2012;307[16]:1727-1735.

Related Stories

Surgery improves endocarditis-induced heart failure survival rates

November 22, 2011
Surgery significantly improves short- and long-term outcomes in patients with heart failure caused by a bacterial infection known as endocarditis, according to Duke University Medical Center researchers.

Cardiovascular implantable electronic device-related infections linked with increased risk of death

September 12, 2011
An association has been found between infection associated with cardiovascular implantable electronic devices (CIEDs) and increases in mortality and hospital care costs, according to a report published Online First by Archives ...

Non-cardiac surgery: Safe for patients with heart device

April 15, 2011
Non-cardiac surgery can be performed safely in patients with a heart device typically implanted into patients waiting for a transplant, according to a study at Henry Ford Hospital in Detroit.

Recommended for you

Some cancer therapies may provide a new way to treat high blood pressure

November 20, 2017
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators. The finding could offer a real advance in hypertension treatment ...

Could this protein protect people against coronary artery disease?

November 17, 2017
The buildup of plaque in the heart's arteries is an unfortunate part of aging. But by studying the genetic makeup of people who maintain clear arteries into old age, researchers led by UNC's Jonathan Schisler, PhD, have identified ...

Raising 'good' cholesterol fails to protect against heart disease

November 16, 2017
Raising so-called 'good' cholesterol by blocking a key protein involved in its metabolism does not protect against heart disease or stroke, according to a large genetic study of 150,000 Chinese adults published in the journal ...

Popular e-cigarette liquid flavorings may change, damage heart muscle cells

November 16, 2017
Chemicals used to make some popular e-cigarette liquid flavorings—including cinnamon, clove, citrus and floral—may cause changes or damage to heart muscle cells, new research indicates.

New model estimates odds of events that trigger sudden cardiac death

November 16, 2017
A new computational model of heart tissue allows researchers to estimate the probability of rare heartbeat irregularities that can cause sudden cardiac death. The model, developed by Mark Walker and colleagues from Johns ...

Possible use for botulinum toxin to treat atrial fibrillation

November 16, 2017
From temporarily softening wrinkles to easing migraines, botulinum toxin has become a versatile medical remedy because of its ability to block nerve signals that can become bothersome or risky.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.